JAMA editorial published online April 8, 2026, titled "ApoB and Resilient Cost-Effectiveness of Statin Intensity" by Ankur Pandya, PhD, and Jinyi Zhu, PhD. The article discusses statin therapy and ASCVD prevention.
💬 Editorial: Simulation modeling demonstrates #ApoB-guided statin intensification is cost-effective, identifies more clinically meaningful risk, and aligns with 2026 ACC/AHA guidelines.
ja.ma/4cxddfa